vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and National Storage Affiliates Trust (NSA). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $187.0M, roughly 1.5× National Storage Affiliates Trust). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 12.2%, a 84.1% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -1.6%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -2.4%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
National Storage Affiliates Trust is a U.S.-headquartered real estate investment trust focused on self-storage assets. It owns, operates and acquires self-storage facilities across dozens of U.S. states, offering secure storage solutions for residential and commercial customers.
ACAD vs NSA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $187.0M |
| Net Profit | $273.6M | $22.9M |
| Gross Margin | 90.8% | 72.5% |
| Operating Margin | 6.1% | 20.2% |
| Net Margin | 96.3% | 12.2% |
| Revenue YoY | 9.4% | -1.6% |
| Net Profit YoY | 90.3% | 36.8% |
| EPS (diluted) | $1.61 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $187.0M | ||
| Q3 25 | $278.6M | $188.7M | ||
| Q2 25 | $264.6M | $188.8M | ||
| Q1 25 | $244.3M | $188.4M | ||
| Q4 24 | $259.6M | $190.1M | ||
| Q3 24 | $250.4M | $193.6M | ||
| Q2 24 | $242.0M | $190.4M | ||
| Q1 24 | $205.8M | $196.1M |
| Q4 25 | $273.6M | $22.9M | ||
| Q3 25 | $71.8M | $18.4M | ||
| Q2 25 | $26.7M | $19.5M | ||
| Q1 25 | $19.0M | $13.0M | ||
| Q4 24 | $143.7M | $16.7M | ||
| Q3 24 | $32.8M | $18.7M | ||
| Q2 24 | $33.4M | $17.1M | ||
| Q1 24 | $16.6M | $59.0M |
| Q4 25 | 90.8% | 72.5% | ||
| Q3 25 | 92.2% | 70.7% | ||
| Q2 25 | 92.2% | 70.5% | ||
| Q1 25 | 91.7% | 70.7% | ||
| Q4 24 | 91.6% | 72.5% | ||
| Q3 24 | 92.5% | 72.8% | ||
| Q2 24 | 92.5% | 72.6% | ||
| Q1 24 | 88.8% | 72.1% |
| Q4 25 | 6.1% | 20.2% | ||
| Q3 25 | 12.8% | 15.8% | ||
| Q2 25 | 12.2% | 16.5% | ||
| Q1 25 | 7.9% | 11.0% | ||
| Q4 24 | 59.1% | 14.5% | ||
| Q3 24 | 12.6% | 15.8% | ||
| Q2 24 | 12.6% | 17.2% | ||
| Q1 24 | 7.4% | 48.9% |
| Q4 25 | 96.3% | 12.2% | ||
| Q3 25 | 25.8% | 9.8% | ||
| Q2 25 | 10.1% | 10.3% | ||
| Q1 25 | 7.8% | 6.9% | ||
| Q4 24 | 55.4% | 8.8% | ||
| Q3 24 | 13.1% | 9.7% | ||
| Q2 24 | 13.8% | 9.0% | ||
| Q1 24 | 8.0% | 30.1% |
| Q4 25 | $1.61 | $0.23 | ||
| Q3 25 | $0.42 | $0.17 | ||
| Q2 25 | $0.16 | $0.19 | ||
| Q1 25 | $0.11 | $0.10 | ||
| Q4 24 | $0.86 | $0.19 | ||
| Q3 24 | $0.20 | $0.18 | ||
| Q2 24 | $0.20 | $0.16 | ||
| Q1 24 | $0.10 | $0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $23.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $946.0M |
| Total Assets | $1.6B | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $23.3M | ||
| Q3 25 | $258.0M | $26.3M | ||
| Q2 25 | $253.6M | $26.1M | ||
| Q1 25 | $217.7M | $19.3M | ||
| Q4 24 | $319.6M | $50.4M | ||
| Q3 24 | $155.1M | $69.9M | ||
| Q2 24 | $177.1M | $59.0M | ||
| Q1 24 | $204.7M | $64.2M |
| Q4 25 | $1.2B | $946.0M | ||
| Q3 25 | $917.3M | $973.1M | ||
| Q2 25 | $822.4M | $1.0B | ||
| Q1 25 | $765.2M | $1.0B | ||
| Q4 24 | $732.8M | $1.1B | ||
| Q3 24 | $577.2M | $986.9M | ||
| Q2 24 | $516.7M | $1.2B | ||
| Q1 24 | $464.0M | $1.3B |
| Q4 25 | $1.6B | $5.1B | ||
| Q3 25 | $1.3B | $5.1B | ||
| Q2 25 | $1.2B | $5.2B | ||
| Q1 25 | $1.1B | $5.3B | ||
| Q4 24 | $1.2B | $5.4B | ||
| Q3 24 | $976.9M | $5.4B | ||
| Q2 24 | $914.1M | $5.3B | ||
| Q1 24 | $855.1M | $5.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $338.5M |
| Free Cash FlowOCF − Capex | — | $299.8M |
| FCF MarginFCF / Revenue | — | 160.3% |
| Capex IntensityCapex / Revenue | — | 20.7% |
| Cash ConversionOCF / Net Profit | -0.18× | 14.79× |
| TTM Free Cash FlowTrailing 4 quarters | — | $541.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $338.5M | ||
| Q3 25 | $74.3M | $100.2M | ||
| Q2 25 | $64.0M | $79.9M | ||
| Q1 25 | $20.3M | $85.6M | ||
| Q4 24 | $40.4M | $363.1M | ||
| Q3 24 | $63.2M | $105.7M | ||
| Q2 24 | $25.0M | $83.2M | ||
| Q1 24 | $29.1M | $94.0M |
| Q4 25 | — | $299.8M | ||
| Q3 25 | $73.9M | $88.0M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $79.9M | ||
| Q4 24 | — | $344.4M | ||
| Q3 24 | $63.2M | $101.8M | ||
| Q2 24 | — | $79.5M | ||
| Q1 24 | — | $88.6M |
| Q4 25 | — | 160.3% | ||
| Q3 25 | 26.5% | 46.6% | ||
| Q2 25 | — | 39.1% | ||
| Q1 25 | — | 42.4% | ||
| Q4 24 | — | 181.2% | ||
| Q3 24 | 25.2% | 52.6% | ||
| Q2 24 | — | 41.7% | ||
| Q1 24 | — | 45.2% |
| Q4 25 | — | 20.7% | ||
| Q3 25 | 0.1% | 6.5% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 2.7% |
| Q4 25 | -0.18× | 14.79× | ||
| Q3 25 | 1.03× | 5.44× | ||
| Q2 25 | 2.40× | 4.10× | ||
| Q1 25 | 1.07× | 6.59× | ||
| Q4 24 | 0.28× | 21.70× | ||
| Q3 24 | 1.93× | 5.65× | ||
| Q2 24 | 0.75× | 4.88× | ||
| Q1 24 | 1.76× | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
NSA
Segment breakdown not available.
